Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 14 998 / https://doi.org/10.3332/ecancer.2020.998

Conference Report

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

At the 2019 International Aspirin Foundation Scientific Conference ‘Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention’, held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.

Keywords: aspirin, primary prevention, secondary prevention, colorectal cancer (CRC), cardiovascular disease (CVD), risk, benefit, precision medicine, antithrombotic, antiplatelet, anticoagulant, upper gastrointestinal (GI) bleeding, gastroprotectant agents, optimi

Loading Article Metrics ... Please wait

Related articles

Case Report: The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases

Abstract | Full Article | PDF Published: 17 Feb 2020 / https://doi.org/10.3332/ecancer.2020.1011

Case Report: Slowly developing toxic epidermal necrolysis-like reaction associated with pemetrexed and carboplatin

Abstract | Full Article | PDF Published: 13 Feb 2020 / https://doi.org/10.3332/ecancer.2020.1010

Case Report: Multiple malignant transformations of an ovarian mature cystic teratoma

Abstract | Full Article | PDF Published: 04 Feb 2020 / https://doi.org/10.3332/ecancer.2020.1009

Review: Inherited lung cancer: a review

Abstract | Full Article | PDF Published: 27 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1008

Research: Health-related quality of life before and during chemotherapy in patients with early-stage breast cancer

Abstract | Full Article | PDF Published: 27 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1007



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation